MKI67 and prostate neoplasm: Although there are no research results reporting the antitumor activity of BITC on an animal prostate tumor model, BITC administration has been reported to decrease the number of Ki67+ cells and to increase that of TUNEL+ apoptotic cells in several other tumor xenograft models [25,31] and in the MMTV-neu transgenic model [35].